Purpose
to respond to the COVID-19 pandemic by developing a SARS-CoV-2 vaccine evaluated through Phase 1 clinical testing
Grantee
Division
Global Health
Date
APRIL 2020
Region served
GLOBAL
Committed amount
$4,019,427
Grant topic
Vaccine Development
Duration (months)
27
Grantee location
Telangana, India
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.